For: | Shinn BJ, Martin A, Coben RM, Conn MI, Prieto J, Kroop H, DiMarino AJ, Hann HW. Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure. World J Hepatol 2019; 11(1): 65-73 [PMID: 30705719 DOI: 10.4254/wjh.v11.i1.65] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v11/i1/65.htm |
Number | Citing Articles |
1 |
Sarah Sauviller, Karen Vergauwen, Steffen Jaensch, Emmanuel Gustin, Danielle Peeters, Peter Vermeulen, Dirk Wuyts, Koen Vandyck, Frederik Pauwels, Jan Martin Berke. Development of a cellular high-content, immunofluorescent HBV core assay to identify novel capsid assembly modulators that induce the formation of aberrant HBV core structures. Journal of Virological Methods 2021; 293: 114150 doi: 10.1016/j.jviromet.2021.114150
|
2 |
Shi Yan Lee, Benjamin Kai Yi Nah, Jazleen Leo, Jia Hong Koh, Daniel Q. Huang. Optimizing care of HBV infection and HBV-related HCC. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000169
|
3 |
Zi-Lin Huang, Wang Li, Qi-Feng Chen, Pei-Hong Wu, Lu-Jun Shen. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets. World Journal of Gastrointestinal Oncology 2019; 11(11): 983-997 doi: 10.4251/wjgo.v11.i11.983
|
4 |
Qi-Feng Chen, Wang Li, Pei-Hong Wu, Lu-Jun Shen, Zi-Lin Huang. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(35): 5266-5282 doi: 10.3748/wjg.v25.i35.5266
|
5 |
Peter D Block, Brianna Shinn, Jin Hyang Kim, Hie-Won Hann. Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes. Hepatic Oncology 2021; 8(1) doi: 10.2217/hep-2020-0028
|
6 |
Tina Boortalary, Brianna Shinn, Dina Halegoua-DeMarzio, Hie-Won Hann. Liver Cancer. 2021; : 109 doi: 10.36255/exonpublications.livercancer.2021.ch6
|
7 |
Rukaiya Bashir Hamidu, Richard R. Hann, Hie-Won Hann. Chronicles of HBV and the Road to HBV Cure. Livers 2023; 3(2): 232 doi: 10.3390/livers3020015
|
8 |
Rukaiya Bashir Hamidu, Divya M. Chalikonda, Hie-Won Hann. Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series. Vaccines 2021; 9(8): 838 doi: 10.3390/vaccines9080838
|
9 |
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study. Clinical and Molecular Hepatology 2023; 29(2): 433 doi: 10.3350/cmh.2022.0316
|
10 |
Qingyan Kong, Mengshi Yi, Fei Teng, Zheyu Chen. Enhanced prognosis of HCC patients undergoing radical treatments with tenofovir versus entecavir: A meta-analysis based on propensity score matching studies. Asian Journal of Surgery 2024; 47(1): 55 doi: 10.1016/j.asjsur.2023.09.057
|
11 |
Nicholas Noverati, Rukaiya Bashir-Hamidu, Dina Halegoua-DeMarzio, Hie-Won Hann. Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress. International Journal of Molecular Sciences 2022; 23(7): 3917 doi: 10.3390/ijms23073917
|
12 |
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, Tina Boortalary, Dina Halegoua-DeMarzio, Hie-Won Hann. Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cancers 2024; 16(4): 777 doi: 10.3390/cancers16040777
|